AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.200
+0.020 (11.11%)
At close: Nov 20, 2024, 4:00 PM
0.197
-0.003 (-1.35%)
After-hours: Nov 20, 2024, 7:58 PM EST
AIM ImmunoTech Employees
As of December 31, 2023, AIM ImmunoTech had 28 total employees, including 26 full-time and 2 part-time employees. The number of employees increased by 4 or 16.67% compared to the previous year.
Employees
28
Change (1Y)
4
Growth (1Y)
16.67%
Revenue / Employee
$6,786
Profits / Employee
-$854,607
Market Cap
12.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 1,003 |
Trinity Biotech | 380 |
ImmunoPrecise Antibodies | 101 |
Turnstone Biologics | 80 |
Aspira Women's Health | 64 |
Sol-Gel Technologies | 36 |
Sensei Biotherapeutics | 28 |
Talphera | 15 |
AIM News
- 2 days ago - AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer - GlobeNewsWire
- 5 days ago - AIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 days ago - AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 12 days ago - Aimia Inc. (AIMFF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and Webcast - GlobeNewsWire
- 17 days ago - AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders - Business Wire
- 7 weeks ago - AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis - GlobeNewsWire
- 7 weeks ago - AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment - GlobeNewsWire